Ireland | 001-35803 | 98-1088325 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit No. | Exhibit | |
99.1 | Recast Historical Financial Information | |
MALLINCKRODT PUBLIC LIMITED COMPANY | ||||
(registrant) | ||||
Date: | October 7, 2016 | By: | /s/ Matthew K. Harbaugh | |
Matthew K. Harbaugh | ||||
Chief Financial Officer |
Exhibit No. | Exhibit | |
99.1 | Recast Historical Financial Information | |
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Nine Months Ended June 24, 2016 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 2,803.4 | $ | (309.8 | ) | $ | 2,493.6 | ||
Cost of sales | 1,290.8 | (162.0 | ) | 1,128.8 | |||||
Gross profit | 1,512.6 | (147.8 | ) | 1,364.8 | |||||
Selling, general and administrative expenses | 722.1 | (64.6 | ) | 657.5 | |||||
Research and development expenses | 198.3 | (4.0 | ) | 194.3 | |||||
Restructuring charges, net | 29.1 | (2.6 | ) | 26.5 | |||||
Non-restructuring impairment charges | 16.9 | — | 16.9 | ||||||
Gains on divestiture and license | (0.5 | ) | 0.5 | — | |||||
Operating income | 546.7 | (77.1 | ) | 469.6 | |||||
Interest expense | (290.6 | ) | — | (290.6 | ) | ||||
Interest income | 0.8 | — | 0.8 | ||||||
Other income (expense), net | — | — | — | ||||||
Income from continuing operations before income taxes | 256.9 | (77.1 | ) | 179.8 | |||||
Income tax (benefit) | (175.0 | ) | (24.2 | ) | (199.2 | ) | |||
Income from continuing operations | 431.9 | (52.9 | ) | 379.0 | |||||
Income from discontinued operations, net of income taxes | 96.8 | 52.9 | 149.7 | ||||||
Net income | $ | 528.7 | $ | — | $ | 528.7 | |||
Basic earnings per share: | |||||||||
Income from continuing operations | $ | 3.87 | $ | 3.39 | |||||
Income from discontinued operations | 0.87 | 1.34 | |||||||
Net income | 4.73 | 4.73 | |||||||
Diluted earnings per share: | |||||||||
Income from continuing operations | $ | 3.84 | $ | 3.37 | |||||
Income from discontinued operations | 0.86 | 1.33 | |||||||
Net income | 4.70 | 4.70 | |||||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 111.7 | 111.7 | |||||||
Diluted | 112.6 | 112.6 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Nine Months Ended June 24, 2016 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | Income from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 1,512.6 | $ | 722.1 | $ | 431.9 | $ | 3.84 | |||||
Reclass to discontinued operations | (147.8 | ) | (64.6 | ) | (52.9 | ) | (0.47 | ) | |||||
Adjusted | 1,364.8 | 657.5 | 379.0 | 3.37 | |||||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 518.8 | (5.4 | ) | 524.2 | 4.66 | ||||||||
Restructuring and related charges, net | 1.2 | (1.8 | ) | 29.5 | 0.26 | ||||||||
Inventory step-up expense | 20.9 | — | 20.9 | 0.19 | |||||||||
Non-restructuring impairment charges | — | — | 16.9 | 0.15 | |||||||||
Change in contingent consideration fair value | — | 10.6 | (10.6 | ) | (0.09 | ) | |||||||
Acquisition related expenses | — | (3.1 | ) | 3.1 | 0.03 | ||||||||
Significant legal and environmental charges | — | (11.5 | ) | 11.5 | 0.10 | ||||||||
Income taxes (1) | — | — | (320.8 | ) | (2.85 | ) | |||||||
As adjusted | $ | 1,905.7 | $ | 646.3 | $ | 653.7 | $ | 5.81 | |||||
Percent of net sales | 76.4 | % | 25.9 | % | 26.2 | % | |||||||
SEGMENT NET SALES | |||||||||
Nine Months Ended June 24, 2016 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 1,667.5 | $ | — | $ | 1,667.5 | |||
Specialty Generics | 785.4 | — | 785.4 | ||||||
Nuclear Imaging | 309.8 | (309.8 | ) | — | |||||
2,762.7 | (309.8 | ) | 2,452.9 | ||||||
Other | 40.7 | — | 40.7 | ||||||
Net sales | $ | 2,803.4 | $ | (309.8 | ) | $ | 2,493.6 | ||
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Three Months Ended June 24, 2016 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 970.6 | $ | (104.0 | ) | $ | 866.6 | ||
Cost of sales | 429.3 | (51.5 | ) | 377.8 | |||||
Gross profit | 541.3 | (52.5 | ) | 488.8 | |||||
Selling, general and administrative expenses | 248.4 | (23.5 | ) | 224.9 | |||||
Research and development expenses | 76.1 | (1.3 | ) | 74.8 | |||||
Restructuring charges, net | 14.1 | (0.1 | ) | 14.0 | |||||
Gains on divestiture and license | (0.2 | ) | 0.2 | — | |||||
Operating income | 202.9 | (27.8 | ) | 175.1 | |||||
Interest expense | (95.6 | ) | — | (95.6 | ) | ||||
Interest income | 0.4 | — | 0.4 | ||||||
Other income (expense), net | (1.3 | ) | — | (1.3 | ) | ||||
Income from continuing operations before income taxes | 106.4 | (27.8 | ) | 78.6 | |||||
Income tax (benefit) | (89.3 | ) | (8.8 | ) | (98.1 | ) | |||
Income from continuing operations | 195.7 | (19.0 | ) | 176.7 | |||||
Income from discontinued operations, net of income taxes | 3.6 | 19.0 | 22.6 | ||||||
Net income | $ | 199.3 | $ | — | $ | 199.3 | |||
Basic earnings per share: | |||||||||
Income from continuing operations | $ | 1.80 | $ | 1.63 | |||||
Income from discontinued operations | 0.03 | 0.21 | |||||||
Net income | 1.84 | 1.84 | |||||||
Diluted earnings per share: | |||||||||
Income from continuing operations | $ | 1.79 | $ | 1.62 | |||||
Income from discontinued operations | 0.03 | 0.21 | |||||||
Net income | 1.82 | 1.82 | |||||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 108.6 | 108.6 | |||||||
Diluted | 109.4 | 109.4 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Three Months Ended June 24, 2016 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | Income from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 541.3 | $ | 248.4 | $ | 195.7 | $ | 1.79 | |||||
Reclass to discontinued operations | (52.5 | ) | (23.5 | ) | (19.0 | ) | (0.17 | ) | |||||
Adjusted | 488.8 | 224.9 | 176.7 | 1.62 | |||||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 174.0 | (1.8 | ) | 175.8 | 1.61 | ||||||||
Restructuring and related charges, net | 0.6 | (0.7 | ) | 15.2 | 0.14 | ||||||||
Inventory step-up expense | 2.6 | — | 2.6 | 0.02 | |||||||||
Change in contingent consideration fair value | — | 4.3 | (4.3 | ) | (0.04 | ) | |||||||
Acquisition related expenses | — | (0.1 | ) | 0.1 | — | ||||||||
Income taxes (1) | — | — | (144.3 | ) | (1.32 | ) | |||||||
As adjusted | $ | 666.0 | $ | 226.6 | $ | 221.8 | $ | 2.03 | |||||
Percent of net sales | 76.9 | % | 26.1 | % | 25.6 | % | |||||||
SEGMENT NET SALES | |||||||||
Three Months Ended June 24, 2016 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 589.3 | $ | — | $ | 589.3 | |||
Specialty Generics | 263.4 | — | 263.4 | ||||||
Nuclear Imaging | 104.0 | (104.0 | ) | — | |||||
956.7 | (104.0 | ) | 852.7 | ||||||
Other | 13.9 | — | 13.9 | ||||||
Net sales | $ | 970.6 | $ | (104.0 | ) | $ | 866.6 | ||
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Three Months Ended March 25, 2016 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 918.0 | $ | (102.2 | ) | $ | 815.8 | ||
Cost of sales | 438.4 | (47.7 | ) | 390.7 | |||||
Gross profit | 479.6 | (54.5 | ) | 425.1 | |||||
Selling, general and administrative expenses | 231.2 | (21.9 | ) | 209.3 | |||||
Research and development expenses | 58.6 | (0.5 | ) | 58.1 | |||||
Restructuring charges, net | 8.7 | (0.3 | ) | 8.4 | |||||
Non-restructuring impairment charges | 16.9 | — | 16.9 | ||||||
Gains on divestiture and license | (0.2 | ) | 0.2 | — | |||||
Operating income | 164.4 | (32.0 | ) | 132.4 | |||||
Interest expense | (97.2 | ) | — | (97.2 | ) | ||||
Interest income | 0.2 | — | 0.2 | ||||||
Other income (expense), net | (0.7 | ) | — | (0.7 | ) | ||||
Income from continuing operations before income taxes | 66.7 | (32.0 | ) | 34.7 | |||||
Income tax (benefit) | (53.6 | ) | (10.2 | ) | (63.8 | ) | |||
Income from continuing operations | 120.3 | (21.8 | ) | 98.5 | |||||
(Loss) income from discontinued operations, net of income taxes | (2.0 | ) | 21.8 | 19.8 | |||||
Net income | $ | 118.3 | $ | — | $ | 118.3 | |||
Basic earnings per share: | |||||||||
Income from continuing operations | $ | 1.08 | $ | 0.89 | |||||
(Loss) income from discontinued operations | (0.02 | ) | 0.18 | ||||||
Net income | 1.06 | 1.06 | |||||||
Diluted earnings per share: | |||||||||
Income from continuing operations | $ | 1.07 | $ | 0.88 | |||||
(Loss) income from discontinued operations | (0.02 | ) | 0.18 | ||||||
Net income | 1.06 | 1.06 | |||||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 111.1 | 111.1 | |||||||
Diluted | 112.0 | 112.0 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Three Months Ended March 25, 2016 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | Income from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 479.6 | $ | 231.2 | $ | 120.3 | $ | 1.07 | |||||
Reclass to discontinued operations | (54.5 | ) | (21.9 | ) | (21.8 | ) | (0.19 | ) | |||||
Adjusted | 425.1 | 209.3 | 98.5 | 0.88 | |||||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 173.2 | (1.8 | ) | 175.0 | 1.56 | ||||||||
Restructuring and related charges, net | 0.6 | (1.1 | ) | 10.1 | 0.09 | ||||||||
Inventory step-up expense | 2.1 | — | 2.1 | 0.02 | |||||||||
Non-restructuring impairment charges | — | — | 16.9 | 0.15 | |||||||||
Acquisition related expenses | — | (1.9 | ) | 1.9 | 0.02 | ||||||||
Change in contingent consideration fair value | — | 6.3 | (6.3 | ) | (0.06 | ) | |||||||
Income taxes (1) | — | — | (95.4 | ) | (0.85 | ) | |||||||
As adjusted | $ | 601.0 | $ | 210.8 | $ | 202.8 | $ | 1.81 | |||||
Percent of net sales | 73.7 | % | 25.8 | % | 24.9 | % | |||||||
SEGMENT NET SALES | |||||||||
Three Months Ended March 25, 2016 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 535.0 | $ | — | $ | 535.0 | |||
Specialty Generics | 264.4 | — | 264.4 | ||||||
Nuclear Imaging | 102.2 | (102.2 | ) | — | |||||
901.6 | (102.2 | ) | 799.4 | ||||||
Other | 16.4 | — | 16.4 | ||||||
Net sales | $ | 918.0 | $ | (102.2 | ) | $ | 815.8 | ||
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Three Months Ended December 25, 2015 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 914.8 | $ | (103.6 | ) | $ | 811.2 | ||
Cost of sales | 423.1 | (62.8 | ) | 360.3 | |||||
Gross profit | 491.7 | (40.8 | ) | 450.9 | |||||
Selling, general and administrative expenses | 242.5 | (19.2 | ) | 223.3 | |||||
Research and development expenses | 63.6 | (2.2 | ) | 61.4 | |||||
Restructuring charges, net | 6.3 | (2.2 | ) | 4.1 | |||||
Gains on divestiture and license | (0.1 | ) | 0.1 | — | |||||
Operating income | 179.4 | (17.3 | ) | 162.1 | |||||
Interest expense | (97.8 | ) | — | (97.8 | ) | ||||
Interest income | 0.2 | — | 0.2 | ||||||
Other income (expense), net | 2.0 | — | 2.0 | ||||||
Income from continuing operations before income taxes | 83.8 | (17.3 | ) | 66.5 | |||||
Income tax (benefit) | (32.1 | ) | (5.2 | ) | (37.3 | ) | |||
Income from continuing operations | 115.9 | (12.1 | ) | 103.8 | |||||
Income from discontinued operations, net of income taxes | 95.2 | 12.1 | 107.3 | ||||||
Net income | $ | 211.1 | $ | — | $ | 211.1 | |||
Basic earnings per share: | |||||||||
Income from continuing operations | $ | 1.00 | $ | 0.90 | |||||
Income from discontinued operations | 0.82 | 0.93 | |||||||
Net income | 1.83 | 1.83 | |||||||
Diluted earnings per share: | |||||||||
Income from continuing operations | $ | 1.00 | $ | 0.89 | |||||
Income from discontinued operations | 0.82 | 0.92 | |||||||
Net income | 1.82 | 1.82 | |||||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 115.4 | 115.4 | |||||||
Diluted | 116.3 | 116.3 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Three Months Ended December 25, 2015 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | Income from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 491.7 | $ | 242.5 | $ | 115.9 | $ | 1.00 | |||||
Reclass to discontinued operations | (40.8 | ) | (19.2 | ) | (12.1 | ) | (0.10 | ) | |||||
Adjusted | 450.9 | 223.3 | 103.8 | 0.89 | |||||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 171.6 | (1.8 | ) | 173.4 | 1.49 | ||||||||
Restructuring and related charges, net | — | — | 4.2 | 0.04 | |||||||||
Inventory step-up expense | 16.2 | — | 16.2 | 0.14 | |||||||||
Acquisition related expenses | — | (1.1 | ) | 1.1 | 0.01 | ||||||||
Significant legal and environmental charges | — | (11.5 | ) | 11.5 | 0.10 | ||||||||
Income taxes (1) | — | — | (81.1 | ) | (0.70 | ) | |||||||
As adjusted | $ | 638.7 | $ | 208.9 | $ | 229.1 | $ | 1.97 | |||||
Percent of net sales | 78.7 | % | 25.8 | % | 28.2 | % | |||||||
SEGMENT NET SALES | |||||||||
Three Months Ended December 25, 2015 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 543.2 | $ | — | $ | 543.2 | |||
Specialty Generics | 257.6 | — | 257.6 | ||||||
Nuclear Imaging | 103.6 | (103.6 | ) | — | |||||
904.4 | (103.6 | ) | 800.8 | ||||||
Other | 10.4 | — | 10.4 | ||||||
Net sales | $ | 914.8 | $ | (103.6 | ) | $ | 811.2 | ||
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Fiscal Year Ended September 25, 2015 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 3,346.9 | $ | (423.8 | ) | $ | 2,923.1 | ||
Cost of sales | 1,493.3 | (193.1 | ) | 1,300.2 | |||||
Gross profit | 1,853.6 | (230.7 | ) | 1,622.9 | |||||
Selling, general and administrative expenses | 1,113.4 | (89.6 | ) | 1,023.8 | |||||
Research and development expenses | 241.5 | (38.2 | ) | 203.3 | |||||
Restructuring charges, net | 40.4 | 4.6 | 45.0 | ||||||
Gains on divestiture and license | (3.5 | ) | 0.5 | (3.0 | ) | ||||
Operating income | 461.8 | (108.0 | ) | 353.8 | |||||
Interest expense | (255.6 | ) | — | (255.6 | ) | ||||
Interest income | 1.0 | — | 1.0 | ||||||
Other income (expense), net | 8.1 | — | 8.1 | ||||||
Income from continuing operations before income taxes | 215.3 | (108.0 | ) | 107.3 | |||||
Income tax (benefit) | (92.9 | ) | (36.4 | ) | (129.3 | ) | |||
Income from continuing operations | 308.2 | (71.6 | ) | 236.6 | |||||
Income from discontinued operations, net of income taxes | 16.5 | 71.6 | 88.1 | ||||||
Net income | $ | 324.7 | $ | — | $ | 324.7 | |||
Basic earnings per share: | |||||||||
Income from continuing operations | $ | 2.64 | $ | 2.03 | |||||
Income from discontinued operations | 0.14 | 0.75 | |||||||
Net income | 2.78 | 2.78 | |||||||
Diluted earnings per share: | |||||||||
Income from continuing operations | $ | 2.61 | $ | 2.00 | |||||
Income from discontinued operations | 0.14 | 0.75 | |||||||
Net income | 2.75 | 2.75 | |||||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 115.8 | 115.8 | |||||||
Diluted | 117.2 | 117.2 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Fiscal Year Ended September 25, 2015 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | Income (loss) from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 1,853.6 | $ | 1,113.4 | $ | 308.2 | $ | 2.61 | |||||
Reclass to discontinued operations | (230.7 | ) | (89.6 | ) | (71.6 | ) | (0.61 | ) | |||||
Adjusted | 1,622.9 | 1,023.8 | 236.6 | 2.00 | |||||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 544.0 | (6.3 | ) | 550.3 | 4.70 | ||||||||
Restructuring and related charges, net | — | — | 45.3 | 0.39 | |||||||||
Inventory step-up expense | 44.1 | — | 44.1 | 0.38 | |||||||||
Incremental equity conversion costs | — | (80.6 | ) | 80.6 | 0.69 | ||||||||
Acquisition related expenses | — | (53.4 | ) | 53.4 | 0.46 | ||||||||
Significant legal and environmental charges | — | (86.3 | ) | 86.3 | 0.74 | ||||||||
Income taxes (1) | — | — | (294.7 | ) | (2.51 | ) | |||||||
Dilutive share impact (2) | — | — | (6.6 | ) | (0.06 | ) | |||||||
As adjusted | $ | 2,211.0 | $ | 797.2 | $ | 795.3 | $ | 6.79 | |||||
Percent of net sales | 75.6 | % | 27.3 | % | 27.2 | % | |||||||
MALLINCKRODT PLC | |||||||||
SEGMENT NET SALES | |||||||||
Fiscal Year Ended September 25, 2015 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 1,622.8 | $ | — | $ | 1,622.8 | |||
Specialty Generics | 1,251.6 | — | 1,251.6 | ||||||
Nuclear Imaging | 423.8 | (423.8 | ) | — | |||||
3,298.2 | (423.8 | ) | 2,874.4 | ||||||
Other | 48.7 | — | 48.7 | ||||||
Net sales | $ | 3,346.9 | $ | (423.8 | ) | $ | 2,923.1 | ||
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Three Months Ended September 25, 2015 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 882.4 | $ | (103.6 | ) | $ | 778.8 | ||
Cost of sales | 400.3 | (47.3 | ) | 353.0 | |||||
Gross profit | 482.1 | (56.3 | ) | 425.8 | |||||
Selling, general and administrative expenses | 285.9 | (18.6 | ) | 267.3 | |||||
Research and development expenses | 70.9 | (9.1 | ) | 61.8 | |||||
Restructuring charges, net | 7.0 | (2.5 | ) | 4.5 | |||||
Gains on divestiture and license | (0.9 | ) | 0.1 | (0.8 | ) | ||||
Operating income | 119.2 | (26.2 | ) | 93.0 | |||||
Interest expense | (76.9 | ) | — | (76.9 | ) | ||||
Interest income | 0.3 | — | 0.3 | ||||||
Other income (expense), net | 0.1 | — | 0.1 | ||||||
Income from continuing operations before income taxes | 42.7 | (26.2 | ) | 16.5 | |||||
Income tax (benefit) | (47.3 | ) | (9.3 | ) | (56.6 | ) | |||
Income from continuing operations | 90.0 | (16.9 | ) | 73.1 | |||||
(Loss) income from discontinued operations, net of income taxes | (14.8 | ) | 16.9 | 2.1 | |||||
Net loss | $ | 75.2 | $ | — | $ | 75.2 | |||
Basic earnings per share: | |||||||||
Income from continuing operations | $ | 0.77 | $ | 0.62 | |||||
Income (loss) from discontinued operations | (0.13 | ) | 0.02 | ||||||
Net income | 0.64 | 0.64 | |||||||
Diluted earnings per share: | |||||||||
Income from continuing operations | $ | 0.76 | $ | 0.62 | |||||
Income (loss) from discontinued operations | (0.13 | ) | 0.02 | ||||||
Net income | 0.63 | 0.63 | |||||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 116.5 | 116.5 | |||||||
Diluted | 117.8 | 117.8 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Three Months Ended September 25, 2015 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | Income (loss) from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 482.1 | $ | 285.9 | $ | 90.0 | $ | 0.76 | |||||
Reclass to discontinued operations | (56.3 | ) | (18.6 | ) | (16.9 | ) | (0.14 | ) | |||||
Adjusted | 425.8 | 267.3 | 73.1 | 0.62 | |||||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 151.7 | (1.9 | ) | 153.6 | 1.30 | ||||||||
Restructuring and related charges, net | — | — | 4.6 | 0.04 | |||||||||
Inventory step-up expense | 4.9 | — | 4.9 | 0.04 | |||||||||
Incremental equity conversion costs | — | (15.6 | ) | 15.6 | 0.13 | ||||||||
Acquisition related expenses | — | (22.8 | ) | 22.8 | 0.19 | ||||||||
Significant legal and environmental charges | — | (19.5 | ) | 19.5 | 0.17 | ||||||||
Income taxes (1) | — | — | (95.0 | ) | (0.81 | ) | |||||||
Dilutive share impact (2) | — | — | (1.2 | ) | (0.01 | ) | |||||||
As adjusted | $ | 582.4 | $ | 207.5 | $ | 197.9 | $ | 1.68 | |||||
Percent of net sales | 74.8 | % | 26.6 | % | 25.4 | % | |||||||
MALLINCKRODT PLC | |||||||||
SEGMENT NET SALES | |||||||||
Three Months Ended September 25, 2015 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 468.7 | $ | — | $ | 468.7 | |||
Specialty Generics | 296.7 | — | 296.7 | ||||||
Nuclear Imaging | 103.6 | (103.6 | ) | — | |||||
869.0 | (103.6 | ) | 765.4 | ||||||
Other | 13.4 | — | 13.4 | ||||||
Net sales | $ | 882.4 | $ | (103.6 | ) | $ | 778.8 | ||
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Three Months Ended June 26, 2015 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 877.3 | $ | (108.8 | ) | $ | 768.5 | ||
Cost of sales | 373.5 | (46.7 | ) | 326.8 | |||||
Gross profit | 503.8 | (62.1 | ) | 441.7 | |||||
Selling, general and administrative expenses | 295.0 | (22.3 | ) | 272.7 | |||||
Research and development expenses | 59.9 | (8.1 | ) | 51.8 | |||||
Restructuring charges, net | 22.7 | (0.2 | ) | 22.5 | |||||
Gains on divestiture and license | (0.9 | ) | 0.2 | (0.7 | ) | ||||
Operating income | 127.1 | (31.7 | ) | 95.4 | |||||
Interest expense | (72.5 | ) | — | (72.5 | ) | ||||
Interest income | 0.2 | — | 0.2 | ||||||
Other income (expense), net | (0.4 | ) | — | (0.4 | ) | ||||
Income from continuing operations before income taxes | 54.4 | (31.7 | ) | 22.7 | |||||
Income tax (benefit) | (1.2 | ) | (10.7 | ) | (11.9 | ) | |||
Income from continuing operations | 55.6 | (21.0 | ) | 34.6 | |||||
Income from discontinued operations, net of income taxes | 2.4 | 21.0 | 23.4 | ||||||
Net income | $ | 58.0 | $ | — | $ | 58.0 | |||
Basic earnings per share: | |||||||||
Income from continuing operations | $ | 0.47 | $ | 0.30 | |||||
Income from discontinued operations | 0.02 | 0.20 | |||||||
Net income | 0.50 | 0.50 | |||||||
Diluted earnings per share: | |||||||||
Income from continuing operations | $ | 0.47 | $ | 0.29 | |||||
Income from discontinued operations | 0.02 | 0.20 | |||||||
Net income | 0.49 | 0.49 | |||||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 116.3 | 116.3 | |||||||
Diluted | 117.8 | 117.8 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Three Months Ended June 26, 2015 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | Income from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 503.8 | $ | 295.0 | $ | 55.6 | $ | 0.47 | |||||
Reclass to discontinued operations | (62.1 | ) | (22.3 | ) | (21.0 | ) | (0.18 | ) | |||||
Adjusted | 441.7 | 272.7 | 34.6 | 0.29 | |||||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 147.1 | (1.9 | ) | 149.0 | 1.26 | ||||||||
Restructuring and related charges, net | — | — | 22.5 | 0.19 | |||||||||
Inventory step-up expense | 4.0 | — | 4.0 | 0.03 | |||||||||
Incremental equity conversion costs | — | (19.6 | ) | 19.6 | 0.17 | ||||||||
Acquisition related expenses | — | (23.5 | ) | 23.5 | 0.20 | ||||||||
Significant legal and environmental charges | — | (15.5 | ) | 15.5 | 0.13 | ||||||||
Income taxes (1) | — | — | (49.6 | ) | (0.42 | ) | |||||||
Dilutive share impact (2) | — | — | (1.6 | ) | (0.01 | ) | |||||||
As adjusted | $ | 592.8 | $ | 212.2 | $ | 217.5 | $ | 1.85 | |||||
Percent of net sales | 77.1 | % | 27.6 | % | 28.3 | % | |||||||
SEGMENT NET SALES | |||||||||
Three Months Ended June 26, 2015 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 446.2 | $ | — | $ | 446.2 | |||
Specialty Generics | 307.9 | — | 307.9 | ||||||
Nuclear Imaging | 108.8 | (108.8 | ) | — | |||||
862.9 | (108.8 | ) | 754.1 | ||||||
Other | 14.4 | — | 14.4 | ||||||
Net sales | $ | 877.3 | $ | (108.8 | ) | $ | 768.5 | ||
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Three Months Ended March 27, 2015 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 819.0 | $ | (109.5 | ) | $ | 709.5 | ||
Cost of sales | 356.1 | (46.3 | ) | 309.8 | |||||
Gross profit | 462.9 | (63.2 | ) | 399.7 | |||||
Selling, general and administrative expenses | 308.4 | (23.9 | ) | 284.5 | |||||
Research and development expenses | 58.0 | (10.0 | ) | 48.0 | |||||
Restructuring charges, net | 3.5 | — | 3.5 | ||||||
Gains on divestiture and license | (0.9 | ) | 0.1 | (0.8 | ) | ||||
Operating income | 93.9 | (29.4 | ) | 64.5 | |||||
Interest expense | (57.4 | ) | — | (57.4 | ) | ||||
Interest income | 0.4 | — | 0.4 | ||||||
Other income (expense), net | 4.2 | — | 4.2 | ||||||
Income from continuing operations before income taxes | 41.1 | (29.4 | ) | 11.7 | |||||
Income tax (benefit) | (34.1 | ) | (9.5 | ) | (43.6 | ) | |||
Income from continuing operations | 75.2 | (19.9 | ) | 55.3 | |||||
Income from discontinued operations, net of income taxes | 23.6 | 19.9 | 43.5 | ||||||
Net income | $ | 98.8 | $ | — | $ | 98.8 | |||
Basic earnings per share: | |||||||||
Income from continuing operations | $ | 0.64 | $ | 0.47 | |||||
Income from discontinued operations | 0.20 | 0.37 | |||||||
Net income | 0.85 | 0.85 | |||||||
Diluted earnings per share: | |||||||||
Income from continuing operations | $ | 0.64 | $ | 0.47 | |||||
Income from discontinued operations | 0.20 | 0.37 | |||||||
Net income | 0.84 | 0.84 | |||||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 115.6 | 115.6 | |||||||
Diluted | 117.2 | 117.2 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Three Months Ended March 27, 2015 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | Income from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 462.9 | $ | 308.4 | $ | 75.2 | $ | 0.64 | |||||
Reclass to discontinued operations | (63.2 | ) | (23.9 | ) | (19.9 | ) | (0.17 | ) | |||||
Adjusted | 399.7 | 284.5 | 55.3 | 0.47 | |||||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 121.8 | (1.1 | ) | 122.9 | 1.05 | ||||||||
Restructuring and related charges, net | — | — | 3.6 | 0.03 | |||||||||
Inventory step-up expense | 4.4 | — | 4.4 | 0.04 | |||||||||
Incremental equity conversion costs | — | (21.6 | ) | 21.6 | 0.18 | ||||||||
Acquisition related expenses | — | (7.1 | ) | 7.1 | 0.06 | ||||||||
Significant legal and environmental charges | — | (51.3 | ) | 51.3 | 0.44 | ||||||||
Income taxes (1) | — | — | (85.2 | ) | (0.73 | ) | |||||||
Dilutive share impact (2) | — | — | (1.6 | ) | (0.01 | ) | |||||||
As adjusted | $ | 525.9 | $ | 203.4 | $ | 179.4 | $ | 1.53 | |||||
Percent of net sales | 74.1 | % | 28.7 | % | 25.3 | % | |||||||
SEGMENT NET SALES | |||||||||
Three Months Ended March 27, 2015 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 334.3 | $ | — | $ | 334.3 | |||
Specialty Generics | 362.8 | — | 362.8 | ||||||
Nuclear Imaging | 109.5 | (109.5 | ) | — | |||||
806.6 | (109.5 | ) | 697.1 | ||||||
Other | 12.4 | — | 12.4 | ||||||
Net sales | $ | 819.0 | $ | (109.5 | ) | $ | 709.5 | ||
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Three Months Ended December 26, 2014 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 768.2 | $ | (101.9 | ) | $ | 666.3 | ||
Cost of sales | 363.4 | (52.8 | ) | 310.6 | |||||
Gross profit | 404.8 | (49.1 | ) | 355.7 | |||||
Selling, general and administrative expenses | 224.1 | (24.8 | ) | 199.3 | |||||
Research and development expenses | 52.7 | (11.0 | ) | 41.7 | |||||
Restructuring charges, net | 7.2 | 7.3 | 14.5 | ||||||
Gains on divestiture and license | (0.8 | ) | 0.1 | (0.7 | ) | ||||
Operating income | 121.6 | (20.7 | ) | 100.9 | |||||
Interest expense | (48.8 | ) | — | (48.8 | ) | ||||
Interest income | 0.1 | — | 0.1 | ||||||
Other income (expense), net | 4.2 | — | 4.2 | ||||||
Income from continuing operations before income taxes | 77.1 | (20.7 | ) | 56.4 | |||||
Income tax (benefit) | (10.3 | ) | (6.9 | ) | (17.2 | ) | |||
Income from continuing operations | 87.4 | (13.8 | ) | 73.6 | |||||
Income from discontinued operations, net of income taxes | 5.3 | 13.8 | 19.1 | ||||||
Net income | $ | 92.7 | $ | — | $ | 92.7 | |||
Basic earnings per share: | |||||||||
Income from continuing operations | $ | 0.75 | $ | 0.63 | |||||
Income from discontinued operations | 0.05 | 0.16 | |||||||
Net income | 0.80 | 0.80 | |||||||
Diluted earnings per share: | |||||||||
Income from continuing operations | $ | 0.74 | $ | 0.63 | |||||
Income from discontinued operations | 0.05 | 0.16 | |||||||
Net income | 0.79 | 0.79 | |||||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 114.8 | 114.8 | |||||||
Diluted | 116.3 | 116.3 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Three Months Ended December 26, 2014 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | Income from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 404.8 | $ | 224.1 | $ | 87.4 | $ | 0.74 | |||||
Reclass to discontinued operations | (49.1 | ) | (24.8 | ) | (13.8 | ) | (0.12 | ) | |||||
Adjusted | 355.7 | 199.3 | 73.6 | 0.63 | |||||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 123.5 | (1.3 | ) | 124.8 | 1.07 | ||||||||
Restructuring and related charges, net | — | — | 14.6 | 0.13 | |||||||||
Inventory step-up expense | 30.8 | — | 30.8 | 0.26 | |||||||||
Incremental equity conversion costs | — | (23.8 | ) | 23.8 | 0.20 | ||||||||
Income taxes (1) | — | — | (64.9 | ) | (0.56 | ) | |||||||
Dilutive share impact (2) | — | — | (2.2 | ) | (0.02 | ) | |||||||
As adjusted | $ | 510.0 | $ | 174.2 | $ | 200.5 | $ | 1.72 | |||||
Percent of net sales | 76.5 | % | 26.1 | % | 30.1 | % | |||||||
SEGMENT NET SALES | |||||||||
Three Months Ended December 26, 2014 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 373.6 | $ | — | $ | 373.6 | |||
Specialty Generics | 284.2 | — | 284.2 | ||||||
Nuclear Imaging | 101.9 | (101.9 | ) | — | |||||
759.7 | (101.9 | ) | 657.8 | ||||||
Other | 8.5 | — | 8.5 | ||||||
Net sales | $ | 768.2 | $ | (101.9 | ) | $ | 666.3 | ||
MALLINCKRODT PLC | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||
Fiscal Year Ended September 26, 2014 | |||||||||
(unaudited, in millions, except per share data) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Net sales | $ | 2,082.0 | $ | (431.7 | ) | $ | 1,650.3 | ||
Cost of sales | 1,021.8 | (256.1 | ) | 765.7 | |||||
Gross profit | 1,060.2 | (175.6 | ) | 884.6 | |||||
Selling, general and administrative expenses | 722.5 | (111.5 | ) | 611.0 | |||||
Research and development expenses | 186.0 | (45.5 | ) | 140.5 | |||||
Restructuring charges, net | 81.4 | (13.4 | ) | 68.0 | |||||
Separation costs | 9.6 | — | 9.6 | ||||||
Non-restructuring impairment charges | 151.6 | (124.5 | ) | 27.1 | |||||
Gains on divestiture and license | (15.0 | ) | — | (15.0 | ) | ||||
Operating (loss) income | (75.9 | ) | 119.3 | 43.4 | |||||
Interest expense | (82.6 | ) | — | (82.6 | ) | ||||
Interest income | 1.5 | — | 1.5 | ||||||
Other income (expense), net | 3.1 | — | 3.1 | ||||||
(Loss) from continuing operations before income taxes | (153.9 | ) | 119.3 | (34.6 | ) | ||||
Income tax (benefit) | (10.1 | ) | (2.5 | ) | (12.6 | ) | |||
(Loss) from continuing operations | (143.8 | ) | 121.8 | (22.0 | ) | ||||
(Loss) from discontinued operations, net of income taxes | (175.5 | ) | (121.8 | ) | (297.3 | ) | |||
Net loss | $ | (319.3 | ) | $ | — | $ | (319.3 | ) | |
Basic earnings per share: | |||||||||
(Loss) from continuing operations | $ | (2.22 | ) | $ | (0.34 | ) | |||
(Loss) from discontinued operations | (2.70 | ) | (4.58 | ) | |||||
Net loss | (4.92 | ) | (4.92 | ) | |||||
Diluted earnings per share: | |||||||||
(Loss) from continuing operations | $ | (2.22 | ) | $ | (0.34 | ) | |||
(Loss) from discontinued operations | (2.70 | ) | (4.58 | ) | |||||
Net loss | (4.92 | ) | (4.92 | ) | |||||
Weighted-average number of shares outstanding: | |||||||||
Basic | 64.9 | 64.9 | |||||||
Diluted | 64.9 | 64.9 | |||||||
MALLINCKRODT PLC | |||||||||||||
NON-GAAP MEASURES | |||||||||||||
Fiscal Year Ended September 26, 2014 | |||||||||||||
(unaudited, in millions except per share data) | |||||||||||||
Gross profit | Selling, general and administrative expenses | (Loss) Income from continuing operations | Diluted income from continuing operations per share | ||||||||||
GAAP | $ | 1,060.2 | $ | 722.5 | $ | (143.8 | ) | $ | (2.22 | ) | |||
Reclass to discontinued operations | (175.6 | ) | (111.5 | ) | 121.8 | 1.88 | |||||||
Adjusted | 884.6 | 611.0 | (22.0 | ) | (0.34 | ) | |||||||
Adjustments: | |||||||||||||
Intangible asset amortization | 153.8 | (1.0 | ) | 154.8 | 2.36 | ||||||||
Restructuring and related charges, net | — | — | 68.2 | 1.04 | |||||||||
Non-restructuring impairment | — | — | 27.1 | 0.41 | |||||||||
Inventory step-up expense | 25.7 | — | 25.7 | 0.39 | |||||||||
Incremental equity conversion costs | — | (13.0 | ) | 13.0 | 0.20 | ||||||||
Separation costs | — | — | 9.6 | 0.15 | |||||||||
Up-front and milestone payments | — | — | 5.0 | 0.08 | |||||||||
Acquisition related expenses | — | (65.1 | ) | 65.1 | 0.99 | ||||||||
Significant legal and environmental charges | (14.3 | ) | (49.6 | ) | 35.3 | 0.54 | |||||||
Gain on intellectual property license | — | — | (11.7 | ) | (0.18 | ) | |||||||
Income taxes (1) | — | — | (88.5 | ) | (1.35 | ) | |||||||
Dilutive share impact (2) | — | — | (0.8 | ) | (0.01 | ) | |||||||
As adjusted | $ | 1,049.8 | $ | 482.3 | $ | 280.8 | $ | 4.27 | |||||
Percent of net sales | 63.6 | % | 29.2 | % | 17.0 | % | |||||||
SEGMENT NET SALES | |||||||||
Fiscal Year Ended September 26, 2014 | |||||||||
(unaudited, in millions) | |||||||||
GAAP Historical As Reported | Reclass to Discontinued Operations | Adjusted | |||||||
Specialty Brands | $ | 413.5 | $ | — | $ | 413.5 | |||
Specialty Generics | 1,199.4 | — | 1,199.4 | ||||||
Nuclear Imaging | 431.7 | (431.7 | ) | — | |||||
2,044.6 | (431.7 | ) | 1,612.9 | ||||||
Other | 37.4 | — | 37.4 | ||||||
Net sales | $ | 2,082.0 | $ | (431.7 | ) | $ | 1,650.3 | ||